When Switching Patients to Biosimilars, Communication & Expert Nurses Reduce the Nocebo Effect
New Clinical Trials for Ustekinumab & Denosumab Biosimilars Begin Recruitment
Health Canada Approves CT-P13 SC for RA; Plus Tofacitinib May Increase Cardiac & Cancer Risks
UnitedHealthcare Designates Avsola, Inflectra Preferred Infliximab Products
FDA Approves New Rituximab Biosimilar & Anakinra to Treat a Rare Disease
Biologics in Rheumatology: Revolution & Perspectives
Patients Demonstrated Good Medication Adherence While Taking Biosimilar Treatment
FDA Approves Golimumab for Patients with pJIA & Psoriatic Arthritis
Biologics May Prevent Cardiovascular Events in RA Patients
- 1
- 2
- 3
- …
- 33
- Next Page »